$776 Million is the total value of SECTORAL ASSET MANAGEMENT INC's 62 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 39.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PTLA | Buy | PORTOLA PHARMACEUTICALS | $27,362,000 | +15.4% | 506,414 | +20.0% | 3.52% | +35.9% |
| TDOC | Buy | TELADOC INC | $24,312,000 | +29.0% | 733,379 | +35.0% | 3.13% | +52.0% |
| LOXO | Buy | LOXO ONCOLOGY INC | $22,590,000 | +27.0% | 245,226 | +10.6% | 2.91% | +49.6% |
| XLRN | Buy | ACCELERON PHARMA | $22,577,000 | +22.9% | 604,957 | +0.1% | 2.91% | +44.7% |
| LJPC | Buy | LA JOLLA PHARMACEUTICAL | $20,920,000 | +19.1% | 601,500 | +2.0% | 2.70% | +40.3% |
| CLVS | Buy | CLOVIS ONCOLOGY | $20,740,000 | +594.3% | 251,699 | +689.0% | 2.67% | +717.1% |
| TSRO | New | TESARO INC | $19,339,000 | – | 149,799 | +100.0% | 2.49% | – |
| UNH | New | UNITEDHEALTH GRP INC | $19,233,000 | – | 98,205 | +100.0% | 2.48% | – |
| GILD | New | GILEAD SCIENCES INC | $19,032,000 | – | 234,900 | +100.0% | 2.45% | – |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS | $16,572,000 | +33.8% | 533,708 | +17.9% | 2.14% | +57.7% |
| MOH | New | MOLINA HEALTHCARE | $15,152,000 | – | 220,359 | +100.0% | 1.95% | – |
| PRTA | Buy | PROTHENA CORP PLC | $12,689,000 | +55.2% | 195,909 | +29.7% | 1.64% | +82.9% |
| EVH | Buy | EVOLENT HEALTH INC | $11,618,000 | -14.0% | 652,680 | +22.5% | 1.50% | +1.4% |
| ONCE | Buy | SPARK THERAPEUTICS | $10,396,000 | +71.8% | 116,599 | +15.1% | 1.34% | +102.3% |
| WMGI | Buy | WRIGHT MED GROUP N V | $9,667,000 | -5.9% | 373,672 | +0.0% | 1.24% | +10.9% |
| IRTC | Buy | IRHYTHM TECHNOLOGIES | $9,608,000 | +22.1% | 185,200 | +0.0% | 1.24% | +44.0% |
| CI | Buy | CIGNA CORP | $8,527,000 | +228.5% | 45,615 | +194.1% | 1.10% | +286.6% |
| ZLAB | New | ZAI LAB LTDadr | $7,171,000 | – | 265,600 | +100.0% | 0.92% | – |
| MNTA | Buy | MOMENTA PHARMACEUTICALS | $6,891,000 | +36.2% | 372,499 | +24.4% | 0.89% | +60.6% |
| EXAS | New | EXACT SCIENCES CORP | $5,539,000 | – | 117,550 | +100.0% | 0.71% | – |
| VRTX | New | VERTEX PHARMACEUTICL | $5,169,000 | – | 34,000 | +100.0% | 0.67% | – |
| RARX | Buy | RA PHARMACEUTICALS | $4,060,000 | +21.2% | 278,082 | +55.6% | 0.52% | +42.9% |
| INCY | Buy | INCYTE CORPORATION | $3,939,000 | +43.2% | 33,745 | +54.5% | 0.51% | +68.4% |
| PTCT | Buy | PTC THERAPEUTICS I | $3,412,000 | +206.6% | 170,535 | +180.8% | 0.44% | +260.7% |
| New | INTEC PHARMA LTD JER | $3,177,000 | – | 355,000 | +100.0% | 0.41% | – | |
| SRPT | Buy | SAREPTA THERAPEUTICS | $3,134,000 | +222.8% | 69,099 | +139.9% | 0.40% | +281.1% |
| ARAY | Buy | ACCURAY INC | $2,750,000 | -1.6% | 687,547 | +16.9% | 0.35% | +15.7% |
| SBPH | Buy | SPRING BK PHARMACEUTICALS | $2,078,000 | +36.4% | 123,383 | +9.7% | 0.27% | +60.5% |
| RDY | Buy | DR REDDYS LABS LTDadr | $1,634,000 | +103.5% | 45,796 | +140.2% | 0.21% | +138.6% |
| Buy | TRILLIUM THERAPEUTCS | $1,206,000 | +49.6% | 234,248 | +27.8% | 0.16% | +76.1% | |
| TGTX | Buy | TG THERAPEUTICS | $1,189,000 | +45.5% | 100,366 | +23.5% | 0.15% | +71.9% |
| CMTA | New | CLEMENTIA PHARMACEUT | $512,000 | – | 30,313 | +100.0% | 0.07% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
| PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
| DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
| GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
| INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
| VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
| AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
| PFIZER INC | 35 | Q3 2023 | 6.3% |
| MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
| MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
| INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
| INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2023-02-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.